FBXO32 and serum lipopolysaccharide activity: Enoxaparin administration substantially alleviated the enhanced expression of calpain, atrogin-1, MuRF-1, LC3-II, and Beclin-1 caused by endotoxemia and MV at VT = 10 mL/kg.